Aims To explore the feasibility of MedicineInsight data to support risk management plan
evaluation, focusing on sodium glucose co-transporter 2 (SGLT2) inhibitors for type 2 diabetes. …

Introduction Antidepressant use during the first trimester is reported in 4–8% of pregnancies.
The use of some selective serotonin reuptake inhibitors during the first trimester has been …

Objective To evaluate the impact of national multifaceted initiatives to improve use of proton
pump inhibitors (PPIs) on the use of PPIs among older Australians. Design Interrupted time …

We conducted a literature review to assess the current status of general practitioner services
in residential aged‐care facilities (RACFs) in Australia and the impact of recent initiatives to …

Background:Antipsychotic agents have limited efficacy for Behavioral and Psychological
Symptoms of Dementia (BPSD) and there are concerns about their safety. Despite this, they are …

Background People with dementia may be particularly sensitive to cognitive impairment
induced by anticholinergic and sedative medicines. Objective This study aimed to examine if …

Background Increased oxycodone use has been associated with adverse drug events, non-medical
use and overdose deaths. Objectives To explore patterns of non-opioid, weak opioid …

Objectives: To determine the impact of four NPS MedicineWise programs targeting quality
use of medicines in cardiovascular management in primary care. Design: Interrupted time‐…

Objective: To explore opioid use by aged care facility residents before and after initiation of
transdermal opioid patches. Design: A cross‐sectional cohort study, analysing pharmacy …

Background: Risperidone is the only antipsychotic approved in Australia for the management
of the behavioural and psychological symptoms of dementia (BPSD). In June 2015, the …